Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma

• Main Authors: Yu Xia (Author), Jiayu Zhong (Author), Mingqi Zhao (Author), Ying Tang (Author), Ning Han (Author), Liang Hua (Author), Tiantian Xu (Author), Changbing Wang (Author), Bing Zhu (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Galactose-modified selenium nanoparticles (GA-SeNPs) loading with doxorubicin (DOX) for hepatocellular carcinoma (HCC) therapy was investigated in this paper. Selenium nanoparticles (SeNPs) were modified with galactose as tumor targeting moiety to fabricate tumor-targeted delivery carrier GA-SeNPs,...